Previous Article | Next Article ![]()
Infection and Immunity, May 2000, p. 3015-3018, Vol. 68, No. 5
Departments of Medicine and Microbiology and
Immunology, Montefiore Medical Center, Albert Einstein College of
Medicine, Bronx,1 and Department of
Chemistry, Brooklyn College, Brooklyn,2 New
York, and The School of Public Health, Harvard Medical
School, Boston, Massachusetts3
Received 8 September 1999/Returned for modification 21 October
1999/Accepted 14 February 2000
Catalase is widely used as a pharmacological probe to evaluate the
role of hydrogen peroxide in antimicrobial activities of phagocytic
cells. This report demonstrates that the ability of a commercial
preparation of catalase to inhibit concomitantly macrophage
antimycobacterial activity and production of reactive nitrogen
intermediates can be attributed, at least in part, to the depletion of
L-arginine by contaminating arginase. In experimental systems that employ pharmacological probes, the existence of
nonspecific effects should be considered in data interpretation.
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
A Commercial Preparation of Catalase Inhibits
Nitric Oxide Production by Activated Murine Macrophages: Role
of Arginase
*
Corresponding author. Mailing address: F406,
Departments of Medicine and Microbiology and Immunology, Albert
Einstein College of Medicine, 1300 Morris Park Ave., Bronx, NY 10461. Phone: (718) 430-2678 or 920-7247. Fax: (718) 652-0536. E-mail:
jchan{at}aecom.yu.edu.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»